לודוטרה 1
rafa laboratories ltd - prednisone 1 mg - tablets modified release - prednisone - for the treatment of moderate to severe, active rheumatoid arthritis in adults particularly when accompanied by morning stiffness
לודוטרה 1
rafa laboratories ltd - prednisone 1 mg - tablets modified release - prednisone - for the treatment of moderate to severe, active rheumatoid arthritis in adults particularly when accompanied by morning stiffness
לודוטרה 2
rafa laboratories ltd - prednisone 2 mg - tablets modified release - prednisone - for the treatment of moderate to severe, active rheumatoid arthritis in adults particularly when accompanied by morning stiffness
לודוטרה 2
rafa laboratories ltd - prednisone 2 mg - tablets modified release - prednisone - for the treatment of moderate to severe, active rheumatoid arthritis in adults particularly when accompanied by morning stiffness
לודוטרה 5
rafa laboratories ltd - prednisone 5 mg - tablets modified release - prednisone - for the treatment of moderate to severe, active rheumatoid arthritis in adults particularly when accompanied by morning stiffness
לודוטרה 5
rafa laboratories ltd - prednisone 5 mg - tablets modified release - prednisone - for the treatment of moderate to severe, active rheumatoid arthritis in adults particularly when accompanied by morning stiffness
סיפרול er 0.375
rafa laboratories ltd - pramipexole dihydrochloride monohydrate 0.375 mg - tablets extended release - pramipexole - treatment of signs and symptoms of idiopathic parkinson's disease, as monotherapy or in combination with levodopa.
סיפרול 0.75 er
rafa laboratories ltd - pramipexole dihydrochloride monohydrate 0.75 mg - tablets extended release - pramipexole - treatment of signs and symptoms of idiopathic parkinson's disease, as monotherapy or in combination with levodopa.
סיפרול 1.5 er
rafa laboratories ltd - pramipexole dihydrochloride monohydrate 1.5 mg - tablets extended release - pramipexole - treatment of signs and symptoms of idiopathic parkinson's disease, as monotherapy or in combination with levodopa.
סיפרול er 4.5 מ"ג
rafa laboratories ltd - pramipexole dihydrochloride monohydrate 4.5 mg - tablets extended release - pramipexole - treatment of signs and symptoms of idiopathic parkinson’s disease, as monotherapy or in combination with lovodopa.